By Chase Doyle
Cristina R. Ferrone, MD

San Diego—With the widespread use of advanced imaging techniques, incidental diagnosis of small pancreatic neuroendocrine tumors has greatly increased in recent years, leading to many challenging clinical decisions. Although tumors smaller than 2 cm are mostly indolent, a significant minority may display aggressive behavior, and optimal treatment remains unclear.

At the 2019 Society of Surgical Oncology Annual Cancer Symposium, Cristina R. Ferrone, MD,